These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 12460903

  • 21. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine.
    Albini A, Morini M, D'Agostini F, Ferrari N, Campelli F, Arena G, Noonan DM, Pesce C, De Flora S.
    Cancer Res; 2001 Nov 15; 61(22):8171-8. PubMed ID: 11719447
    [Abstract] [Full Text] [Related]

  • 22. Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth.
    Martínez A, Zudaire E, Portal-Núñez S, Guédez L, Libutti SK, Stetler-Stevenson WG, Cuttitta F.
    Cancer Res; 2004 Sep 15; 64(18):6489-94. PubMed ID: 15374959
    [Abstract] [Full Text] [Related]

  • 23. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
    Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM.
    Cancer Res; 2001 Dec 15; 61(24):8730-6. PubMed ID: 11751392
    [Abstract] [Full Text] [Related]

  • 24. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 25. Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway.
    Bauer KS, Cude KJ, Dixon SC, Kruger EA, Figg WD.
    J Pharmacol Exp Ther; 2000 Jan 17; 292(1):31-7. PubMed ID: 10604929
    [Abstract] [Full Text] [Related]

  • 26. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK.
    Clin Cancer Res; 2000 Aug 17; 6(8):3354-60. PubMed ID: 10955823
    [Abstract] [Full Text] [Related]

  • 27. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG, Kim TD, Li G, Yoon WH, Chae CB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646
    [Abstract] [Full Text] [Related]

  • 28. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA, Luo JX, Zhang TY, Hu ZS, Wang FY.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):354-60. PubMed ID: 15120609
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.
    Li X, Jiang L, Wang Y, Xiao Y, Huang Y, Yao Q, Yang Y, Wu X.
    Cancer Lett; 2007 Oct 18; 256(1):29-32. PubMed ID: 17574330
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth factor.
    Vitaliti A, Wittmer M, Steiner R, Wyder L, Neri D, Klemenz R.
    Cancer Res; 2000 Aug 15; 60(16):4311-4. PubMed ID: 10969766
    [Abstract] [Full Text] [Related]

  • 31. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
    Juarez JC, Guan X, Shipulina NV, Plunkett ML, Parry GC, Shaw DE, Zhang JC, Rabbani SA, McCrae KR, Mazar AP, Morgan WT, Doñate F.
    Cancer Res; 2002 Sep 15; 62(18):5344-50. PubMed ID: 12235005
    [Abstract] [Full Text] [Related]

  • 32. The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules.
    Bikfalvi A, Gimenez-Gallego G.
    Semin Thromb Hemost; 2004 Feb 15; 30(1):137-44. PubMed ID: 15034805
    [Abstract] [Full Text] [Related]

  • 33. Amifostine inhibits angiogenesis in vivo.
    Giannopoulou E, Katsoris P, Kardamakis D, Papadimitriou E.
    J Pharmacol Exp Ther; 2003 Feb 15; 304(2):729-37. PubMed ID: 12538828
    [Abstract] [Full Text] [Related]

  • 34. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.
    Zilberberg L, Shinkaruk S, Lequin O, Rousseau B, Hagedorn M, Costa F, Caronzolo D, Balke M, Canron X, Convert O, Laïn G, Gionnet K, Goncalvès M, Bayle M, Bello L, Chassaing G, Deleris G, Bikfalvi A.
    J Biol Chem; 2003 Sep 12; 278(37):35564-73. PubMed ID: 12837752
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
    Shimamura M, Hazato T, Ashino H, Yamamoto Y, Iwasaki E, Tobe H, Yamamoto K, Yamamoto S.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):220-4. PubMed ID: 11708802
    [Abstract] [Full Text] [Related]

  • 36. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ, Wang X, Kachhap SK, Kato Y, Wei Y, Zhang L, Atadja P, Pili R.
    Cancer Res; 2004 Sep 15; 64(18):6626-34. PubMed ID: 15374977
    [Abstract] [Full Text] [Related]

  • 37. Anti-angiogenic activity of the purine analog 6-thioguanine.
    Presta M, Belleri M, Vacca A, Ribatti D.
    Leukemia; 2002 Aug 15; 16(8):1490-9. PubMed ID: 12145690
    [Abstract] [Full Text] [Related]

  • 38. Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth.
    Rhim TY, Park CS, Kim E, Kim SS.
    Biochem Biophys Res Commun; 1998 Nov 18; 252(2):513-6. PubMed ID: 9826562
    [Abstract] [Full Text] [Related]

  • 39. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
    Casu B, Guerrini M, Guglieri S, Naggi A, Perez M, Torri G, Cassinelli G, Ribatti D, Carminati P, Giannini G, Penco S, Pisano C, Belleri M, Rusnati M, Presta M.
    J Med Chem; 2004 Feb 12; 47(4):838-48. PubMed ID: 14761186
    [Abstract] [Full Text] [Related]

  • 40. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B, Li B, Russell SJ, Tom JY, Cochran AG, Fairbrother WJ.
    J Mol Biol; 2002 Feb 22; 316(3):769-87. PubMed ID: 11866530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.